Medartis Holding AG Market Cap ($1.04 Billion)

$1.04 Billion USD  · CHF821.06 Million CHF  · Rank #8380

Market Cap & Net Worth: Medartis Holding AG (MED)

Medartis Holding AG market cap. Medartis Holding AG (SW:MED) has a market capitalization of $1.04 Billion (CHF821.06 Million) as of November 1, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #8380 globally and #118 in its home market, demonstrating a 5.89% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medartis Holding AG's stock price CHF97.10 by its total outstanding shares 12446490 (12.45 Million). Also see Medartis Holding AG cash conversion from operations for how efficiently the company converts equity into cash flow.

Medartis Holding AG Market Cap History (2018–2026)

Medartis Holding AG market cap history from 2018 to 2026. Data shows growth from $871.76 Million to $1.53 Billion (5.36% CAGR). Check MED live share price for real-time trading data and today's change.

Medartis Holding AG Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Medartis Holding AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Medartis Holding AG (MED) equity growth momentum to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

5.15x

Medartis Holding AG's market cap is 5.15 times its annual revenue

Industry average: 1.49x Higher than industry average

Latest Price to Earnings (P/E) Ratio

166.23x

Medartis Holding AG's market cap is 166.23 times its annual earnings

Industry average: 18.23x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2018 $871.76 Million $121.32 Million $4.20 Million 7.19x 207.47x
2019 $687.65 Million $130.14 Million $2.15 Million 5.28x 320.36x
2020 $731.71 Million $127.65 Million -$943.57K 5.73x N/A
2021 $2.05 Billion $159.88 Million $6.84 Million 12.81x 299.62x
2022 $1.29 Billion $182.82 Million -$5.78 Million 7.06x N/A
2023 $1.32 Billion $212.01 Million $619.00K 6.23x 2135.38x
2024 $890.64 Million $224.83 Million $3.53 Million 3.96x 252.45x
2025 $1.39 Billion $269.26 Million $8.35 Million 5.15x 166.23x

Competitor Companies of MED by Market Capitalization

Companies near Medartis Holding AG in the global market cap rankings as of November 1, 2026. Also see Medartis Holding AG asset portfolio for a full breakdown of the balance sheet.

Key companies related to Medartis Holding AG by market ranking:

  • Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
  • Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
  • Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
  • Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#114 Abbott Laboratories NYSE:ABT $184.67 Billion $106.20
#215 Stryker Corporation NYSE:SYK $111.95 Billion $291.86
#225 Medtronic PLC NYSE:MDT $109.30 Billion $96.54
#241 Medtronic plc SA:MDTC34 $104.84 Billion R$208.39

Market Capitalization of Medartis Holding AG (2018–2026)

Market capitalization of Medartis Holding AG from 2018 to today. Between 2018 and today, Medartis Holding AG's market cap moved from $871.76 Million to $ 1.53 Billion, with a yearly change of 5.36%.

Year Market Cap Change (%)
2026 CHF1.53 Billion +10.09%
2025 CHF1.39 Billion +55.83%
2024 CHF890.64 Million -32.62%
2023 CHF1.32 Billion +2.44%
2022 CHF1.29 Billion -37.02%
2021 CHF2.05 Billion +180.00%
2020 CHF731.71 Million +6.41%
2019 CHF687.65 Million -21.12%
2018 CHF871.76 Million --

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of Medartis Holding AG was reported to be:

Source Market Cap
Yahoo Finance $1.04 Billion USD
MoneyControl $1.04 Billion USD
MarketWatch $1.04 Billion USD
marketcap.company $1.04 Billion USD
Reuters $1.04 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Medartis Holding AG

SW:MED Switzerland Medical Devices
Market Cap
$1.53 Billion
CHF1.21 Billion CHF
Market Cap Rank
#8380 Global
#118 in Switzerland
Share Price
CHF97.10
Change (1 day)
-0.21%
52-Week Range
CHF72.00 - CHF97.50
All Time High
CHF145.60
About

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, a… Read more